Literature DB >> 26835302

Pediatric Hodgkin Lymphoma: on the road to a 'radiotherapy-free' cure rate?-Commentary on a report on final results of the Multinational Trial GPOH-HD95.

Gaetano Corazzelli1.   

Abstract

Entities:  

Year:  2013        PMID： 26835302      PMCID： PMC4728935          DOI： 10.3978/j.issn.2224-4336.2013.05.02

Source DB:  PubMed          Journal:  Transl Pediatr        ISSN： 2224-4336


× No keyword cloud information.
  24 in total

1.  Hematology: Treatment strategies for pediatric Hodgkin lymphoma.

Authors:  John T Sandlund; Melissa M Hudson
Journal:  Nat Rev Clin Oncol       Date:  2010-05       Impact factor: 66.675

2.  Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study.

Authors:  Christine Mauz-Körholz; Dirk Hasenclever; Wolfgang Dörffel; Kathrin Ruschke; Tanja Pelz; Antje Voigt; Martina Stiefel; Melanie Winkler; Constanze Vilser; Karin Dieckmann; Jonas Karlén; Eva Bergsträsser; Alexander Fosså; Georg Mann; Michael Hummel; Wolfram Klapper; Harald Stein; Dirk Vordermark; Regine Kluge; Dieter Körholz
Journal:  J Clin Oncol       Date:  2010-07-12       Impact factor: 44.544

Review 3.  Decision analysis on alternative treatment strategies for favorable-prognosis, early-stage Hodgkin's disease.

Authors:  A K Ng; J C Weeks; P M Mauch; K M Kuntz
Journal:  J Clin Oncol       Date:  1999-11       Impact factor: 44.544

4.  Guidelines for the pediatric cancer center and role of such centers in diagnosis and treatment. American Academy of Pediatrics Section Statement Section on Hematology/Oncology.

Authors: 
Journal:  Pediatrics       Date:  1997-01       Impact factor: 7.124

5.  Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection.

Authors:  Mário Henrique M Barros; Gabriela Vera-Lozada; Fernando A Soares; Gerald Niedobitek; Rocio Hassan
Journal:  Int J Cancer       Date:  2011-12-21       Impact factor: 7.396

6.  ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.

Authors:  Simonetta Viviani; Pier Luigi Zinzani; Alessandro Rambaldi; Ercole Brusamolino; Alessandro Levis; Valeria Bonfante; Umberto Vitolo; Alessandro Pulsoni; Anna Marina Liberati; Giorgina Specchia; Pinuccia Valagussa; Andrea Rossi; Francesco Zaja; Enrico M Pogliani; Patrizia Pregno; Manuel Gotti; Andrea Gallamini; Delia Rota Scalabrini; Gianni Bonadonna; Alessandro M Gianni
Journal:  N Engl J Med       Date:  2011-07-21       Impact factor: 91.245

Review 7.  Pediatric hodgkin lymphoma: maximizing efficacy and minimizing toxicity.

Authors:  David C Hodgson; Melissa M Hudson; Louis S Constine
Journal:  Semin Radiat Oncol       Date:  2007-07       Impact factor: 5.934

8.  Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95.

Authors:  Wolfgang Dörffel; Ursula Rühl; Heike Lüders; Alexander Claviez; Marion Albrecht; Jos Bökkerink; Harald Holte; Jonas Karlen; Georg Mann; Heinz Marciniak; Felix Niggli; Kjeld Schmiegelow; Ernst-Wilhelm Schwarze; Richard Pötter; Lutz Wickmann; Günther Schellong
Journal:  J Clin Oncol       Date:  2013-03-18       Impact factor: 44.544

9.  ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.

Authors:  Massimo Federico; Stefano Luminari; Emilio Iannitto; Giuseppe Polimeno; Luigi Marcheselli; Antonella Montanini; Antonio La Sala; Francesco Merli; Caterina Stelitano; Samantha Pozzi; Renato Scalone; Nicola Di Renzo; Pellegrino Musto; Luca Baldini; Giulia Cervetti; Francesco Angrilli; Patrizio Mazza; Maura Brugiatelli; Paolo G Gobbi
Journal:  J Clin Oncol       Date:  2009-01-05       Impact factor: 44.544

Review 10.  Treatment of pediatric hodgkin lymphoma.

Authors:  Michael R Olson; Sarah S Donaldson
Journal:  Curr Treat Options Oncol       Date:  2008-05-07
View more
  1 in total

1.  A U.S. population-based study of insurance disparities in cancer survival among adolescents and young adults.

Authors:  Meryl D Colton; DeLayna Goulding; Alina Beltrami; Carrye Cost; Anna Franklin; Myles G Cockburn; Adam L Green
Journal:  Cancer Med       Date:  2019-06-26       Impact factor: 4.452
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.